Robert More
Vorsitzender bei TYRA BIOSCIENCES, INC.
Vermögen: 485 503 $ am 31.01.2025
Profil
Robert J.
More is currently the Chairman at Affinivax, Inc. and Tyra Biosciences, Inc. He is also the Managing Director at Alta Partners Management Co. LP.
In addition, he holds director positions at Acureon Pharmaceuticals, Inc., Biotechnology Innovation Organization, Sirenas LLC, Nuon Therapeutics, Inc., Vir Biotechnology, Inc., Variant Bio, Inc., Mbrace Therapeutics, Inc., Kelonia Therapeutics, Inc., and Amplitude Therapeutics, Inc. Previously, Mr. More served as the Chairman of Intercept Pharmaceuticals, Inc. He also held director positions at TargetRx, Inc., ESP Pharma, Inc., Receptor BioLogix, Inc., AMO Development LLC, PatientKeeper, Inc., Achaogen, Inc., NovaCardia, Inc., Esprit Pharma, Inc., and Foundation for Innovative New Diagnostics.
From 2001 to 2015, he was a director at Glaukos Corp.
He also served as a director at Apnex Medical, Inc., One Revolution Entertainment LLC, Cytyc Surgical Products II, Inc., Carticept Medical, Inc., Society of Kauffman Fellows, Oceana Therapeutics, Inc., Neothetics, Inc., Moximed, Inc., Cartiva, Inc., eGenesis, Inc., Hangzhou Qihan Biotech Co., Ltd., Proxima Therapeutics, Inc., and Sienna Biopharmaceuticals, Inc. From 2008 to 2013, he was a General Partner at Frazier Management LLC.
Prior to that, he was a Partner at Domain Associates LLC from 1996 to 2008.
He also served as the Chief Operating Officer at Morphochem, Inc. and as a Senior Advisor at Bill & Melinda Gates Foundation Trust (Investment Management).
Mr. More completed his undergraduate degree at Middlebury College in 1989.
He also holds an MBA from the University of Virginia Darden School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
VIR BIOTECHNOLOGY, INC.
0,03 % | 30.05.2024 | 46 683 ( 0,03 % ) | 485 503 $ | 31.01.2025 |
TYRA BIOSCIENCE, INC
-.--% | 29.05.2024 | 0 ( -.--% ) | - $ | 31.01.2025 |
Aktuelle Nachrichten zu Robert More
Aktive Positionen von Robert More
Unternehmen | Position | Beginn |
---|---|---|
VIR BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.09.2016 |
TYRA BIOSCIENCES, INC. | Vorsitzender | 01.03.2019 |
Sirenas LLC
![]() Sirenas LLC Pharmaceuticals: MajorHealth Technology Sirenas LLC research and develops marine inspired pre-clinical leads for cancer, human immunodeficiency virus and infectious diseases. The company was founded by Jake Beverage, Eduardo Esquenazi and Phil Baran and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Affinivax, Inc.
![]() Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Vorsitzender | - |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - |
Kelonia Therapeutics, Inc.
![]() Kelonia Therapeutics, Inc. BiotechnologyHealth Technology Kelonia Therapeutics, Inc. is a company based in Cambridge, MA that is pioneering a new wave of genetic medicines using its in vivo gene placement system (iGPS™). The company's simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. Initially focused on developing transformational in vivo CAR T therapies for hematologic cancers, Kelonia Therapeutics is building a pipeline of genetic medicines for a range of diseases, with the bold goal of making genetic medicines accessible to every patient in need, when and where they need them. The company was founded by Michael Fischbach, Michael Birnbaum. | Direktor/Vorstandsmitglied | - |
Mbrace Therapeutics, Inc.
![]() Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Variant Bio, Inc.
![]() Variant Bio, Inc. BiotechnologyHealth Technology Variant Bio, Inc. is a biotechnology company, which engages in the development of new generation of therapeutics. It focuses on traits of medical relevance and using genomics. The company was founded by Akhila Kosaraju, Kaja Wasik, and Stephane Castel in 2018 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Acureon Pharmaceuticals, Inc.
![]() Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Acureon Pharmaceuticals, Inc. develops and markets therapeutics for infectious diseases. The firm’s synergistic combination of anti-infective expertise, dedicated clinical operations, marketing know-how and intellectual property, all coupled with well documented low attrition rates for anti-infective should translate into multiple product opportunities with a lower risk of failure, more rapid development timelines and early substantial returns on investment. The company was founded by Giorgio Mosconi in 2006 and is headquartered in Berwyn, PA. | Direktor/Vorstandsmitglied | - |
░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Ehemalige bekannte Positionen von Robert More
Unternehmen | Position | Ende |
---|---|---|
░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Robert More
University of Virginia Darden School of Business | Masters Business Admin |
Middlebury College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
GLAUKOS CORPORATION | Health Technology |
SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
TYRA BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 36 |
---|---|
Domain Associates LLC
![]() Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded by Jesse I. Treu in 1985. The firm is headquartered in Princeton, New Jersey. | Finance |
Nuon Therapeutics, Inc.
![]() Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Health Technology |
NovaCardia, Inc.
![]() NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Health Technology |
Receptor BioLogix, Inc.
![]() Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Health Technology |
Morphochem, Inc.
![]() Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Morphochem, Inc. manufactures and develops drugs. It uses proprietary whole-cell high throughput screening systems to discover novel compounds of therapeutic value for disorders including cancer & immunological, infectious & metabolic diseases, and for applications in agriculture. The company was founded by Prabhavathi Fernandes in 1997 and is located in Monmouth Junction, NJ | Health Technology |
Acureon Pharmaceuticals, Inc.
![]() Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Acureon Pharmaceuticals, Inc. develops and markets therapeutics for infectious diseases. The firm’s synergistic combination of anti-infective expertise, dedicated clinical operations, marketing know-how and intellectual property, all coupled with well documented low attrition rates for anti-infective should translate into multiple product opportunities with a lower risk of failure, more rapid development timelines and early substantial returns on investment. The company was founded by Giorgio Mosconi in 2006 and is headquartered in Berwyn, PA. | Retail Trade |
Carticept Medical, Inc.
![]() Carticept Medical, Inc. Medical SpecialtiesHealth Technology Carticept Medical, Inc. develops and markets medical devices. It develops platform technologies to improve the safety, efficiency, and accuracy of many common injection procedures. The firm's Navigator Delivery System, a FDA-cleared computer controlled medication delivery system for intra-articular injections. The company was founded by Timothy J. Patrick and Peter J. Pizzo, III in 2005 and is headquartered in Alpharetta, GA. | Health Technology |
Apnex Medical, Inc.
![]() Apnex Medical, Inc. Medical SpecialtiesHealth Technology Apnex Medical, Inc. manufactured medical devices. It developed a proprietary active implantable medical device for the treatment of obstructive sleep apnea (OSA). The company was founded by Chad J. Kugler, Michael L. Berman and Robert E. Atkinson in 2006 and was headquartered in St. Paul, MN. | Health Technology |
Alta Partners Management Co. LP
![]() Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
Frazier Management LLC
![]() Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Oceana Therapeutics, Inc.
![]() Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Health Technology |
Achaogen, Inc.
![]() Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Moximed, Inc.
![]() Moximed, Inc. Medical SpecialtiesHealth Technology Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA. | Health Technology |
PatientKeeper, Inc.
![]() PatientKeeper, Inc. Packaged SoftwareTechnology Services PatientKeeper, Inc. provides healthcare applications for physicians. Its clinical solutions include Computerized Physician Order Entry (CPOE), Mobile CPOE, Medication Reconciliation, NoteWriter, Mobile Clinical Results, Physician Portal, ePrescription, Sign-Out, eSignature and Provider Directory. The firm’s financial solutions include PatientKeeper Charge Capture, PatientKeeper Analytics and PatientKeeper PQRS. It operates through its offices located in Boston and Chicago. The company was founded by Stephen Hau and Joseph Vincent Bonventre in 1996 and is headquartered in Boston, MA. | Technology Services |
Intercept Pharmaceuticals, Inc.
![]() Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002, and is headquartered in Morristown, NJ. | Health Technology |
Cartiva, Inc.
![]() Cartiva, Inc. Medical SpecialtiesHealth Technology Cartiva, Inc. develops and manufactures medical devices. It provides devices for patients with osteoarthritis, cartilage damage and other musculoskeletal conditions. The company was founded in 2011 and is headquartered in Alpharetta, GA. | Health Technology |
TargetRx, Inc.
![]() TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services TargetRx, Inc. provides pharmaceutical and biotech enterprises with insight into the drivers of prescribing. The firm offers various solutions, which include forecasting, positioning, and promotional decisions for new drug launches; optimizing marketing messages and materials for campaign development; and measurement and optimization of execution for sales and marketing execution. TargetRx was founded by Michael J. Luby and Sangam Pant in 1999 and is headquartered in Horsham, PA. | Commercial Services |
eGenesis, Inc.
![]() eGenesis, Inc. Medical/Nursing ServicesHealth Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Health Services |
AMO Development LLC
![]() AMO Development LLC Medical SpecialtiesHealth Technology AMO Development LLC designs, develops and manufactures femtosecond laser technology for use in ophthalmology. It offers Keratoplasty a blade-free laser approach used to incise corneal tissue. The firm's products include metal cone and glass lens for disposable patient interface. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Technology |
Cytyc Surgical Products II, Inc.
![]() Cytyc Surgical Products II, Inc. Medical SpecialtiesHealth Technology Cytyc Surgical Products II, Inc. was a manufacturer of medical devices. It was established in 1995 to develop site-specific cancer treatment systems for malignant tumors. Some of its products inluded MammoSite RTS for breast cancer and GliaSite RTS for brain cancer. The firm was headquartered in Alpharetta, GA. | Health Technology |
Esprit Pharma, Inc.
![]() Esprit Pharma, Inc. Pharmaceuticals: MajorHealth Technology Esprit Pharma, Inc. manufactures and supplies pharmaceutical products. The company offers SANCTURA, a treatment for over-active bladder and PRO-QUIN, a treatment for urinary tract infections. The company was founded in 2005 and is headquartered in East Brunswick, NJ. | Health Technology |
One Revolution Entertainment LLC | |
Foundation for Innovative New Diagnostics
![]() Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Health Services |
Society of Kauffman Fellows
![]() Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | Commercial Services |
Sirenas LLC
![]() Sirenas LLC Pharmaceuticals: MajorHealth Technology Sirenas LLC research and develops marine inspired pre-clinical leads for cancer, human immunodeficiency virus and infectious diseases. The company was founded by Jake Beverage, Eduardo Esquenazi and Phil Baran and is headquartered in San Diego, CA. | Health Technology |
Affinivax, Inc.
![]() Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Neothetics, Inc.
![]() Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
Hangzhou Qihan Biotech Co., Ltd.
![]() Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotechnology company founded in 2017 by two pioneers in genome editing technology, George McDonald Church and Luhan Yang. Hangzhou Qihan Biotech Co., Ltd. is based in Hangzhou, China, and has subsidiaries in China. Qihan Biotech applies high-throughput, multiplexable genome editing technology to develop novel cell therapies and organs for transplantation. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for the treatment of cancer, autoimmune diseases, organ failure, and other complex medical conditions. Qihan Biotech has raised two financing rounds and has multiple products in different stages of development, including qn-019a, which has received IND approval from NMPA to treat CD19-positive relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. With their deep scientific experience and technological advancements, Qihan Biotech is at the forefront of cutting-edge cell therapy products. Luhan Yang has been the CEO of the company since 2017. | Health Services |
Variant Bio, Inc.
![]() Variant Bio, Inc. BiotechnologyHealth Technology Variant Bio, Inc. is a biotechnology company, which engages in the development of new generation of therapeutics. It focuses on traits of medical relevance and using genomics. The company was founded by Akhila Kosaraju, Kaja Wasik, and Stephane Castel in 2018 and is headquartered in New York, NY. | Health Technology |
Proxima Therapeutics, Inc.
![]() Proxima Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Proxima Therapeutics, Inc. develops radiation delivery systems for the treatment of solid cancerous tumors. The CEO of the American company is Timothy J. Patrick. | Commercial Services |
Kelonia Therapeutics, Inc.
![]() Kelonia Therapeutics, Inc. BiotechnologyHealth Technology Kelonia Therapeutics, Inc. is a company based in Cambridge, MA that is pioneering a new wave of genetic medicines using its in vivo gene placement system (iGPS™). The company's simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. Initially focused on developing transformational in vivo CAR T therapies for hematologic cancers, Kelonia Therapeutics is building a pipeline of genetic medicines for a range of diseases, with the bold goal of making genetic medicines accessible to every patient in need, when and where they need them. The company was founded by Michael Fischbach, Michael Birnbaum. | Health Technology |
Mbrace Therapeutics, Inc.
![]() Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Health Technology |
Bill & Melinda Gates Foundation Trust (Investment Management)
![]() Bill & Melinda Gates Foundation Trust (Investment Management) Investment Trusts/Mutual FundsMiscellaneous Bill & Melinda Gates Foundation Trust (Investment Management) (Foundation Trust-IM) is the investment management division of Bill & Melinda Gates Foundation Trust, a private philanthropic foundation headquartered in Seattle, Washington. The firm was founded by Microsoft cofounder Bill Gates and his wife Melinda Gates in 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation (established in 1994), which focused on improving global health. Foundation Trust-IM manages the endowment assets. The Foundation Trust participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The Foundation also provides funds to promote greater equity in global health, education and public libraries. | Miscellaneous |
ESP Pharma, Inc.
![]() ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | Health Technology |
Amplitude Therapeutics, Inc.
![]() Amplitude Therapeutics, Inc. BiotechnologyHealth Technology Amplitude Therapeutics, Inc. operates as a biotechnology company focusing on developing the medicine. The company is based in Boston, MA. | Health Technology |